CVS Health posts strong Q3 results and lifts 2026 outlook while outlining a split
CVS Health reported third‑quarter adjusted earnings of $2.09 per share, well above the $1.65 consensus. Revenue climbed to $108.4 billion, a 5.4% increase year over year. The company raised its 2026 adjusted EPS target to at least $8.20 and its full‑year cash‑flow goal to a minimum of $15.5 billion. It also disclosed a plan to divide into two publicly traded entities by the first half of 2028.
Why it matters
The higher earnings guidance suggests stronger profitability than analysts expected, which could support the stock price. The announced split creates two separate businesses, potentially altering the risk profile for investors in each new company.
Key facts
- 1Adjusted EPS for Q3 2026 was $2.09, up from $1.60 a year earlier. tradingview.com
- 2Quarterly revenue reached $108.4 billion, a 5.4% year‑over‑year increase. investing.com
- 32026 adjusted EPS guidance was lifted to at least $8.20, from a prior range of $7.90‑$8.10. investing.com
- 4Full‑year 2026 cash‑flow guidance was raised to at least $15.5 billion, up from at least $11.5 billion. investing.com
- 5CVS announced a tax‑free separation into two independent companies by the first half of 2028. investing.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.